These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31075260)

  • 21. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.
    Pulvirenti T; Van Der Heijden M; Droms LA; Huse JT; Tabar V; Hall A
    Cancer Res; 2011 Dec; 71(23):7280-90. PubMed ID: 21990322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.
    Zeng A; Yin J; Li Y; Li R; Wang Z; Zhou X; Jin X; Shen F; Yan W; You Y
    Cell Death Dis; 2018 Mar; 9(3):394. PubMed ID: 29531296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
    Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
    Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway.
    Kouchi M; Shibayama Y; Ogawa D; Miyake K; Nishiyama A; Tamiya T
    J Neurosurg; 2017 Oct; 127(4):819-828. PubMed ID: 28059652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.
    Suwala AK; Hanaford A; Kahlert UD; Maciaczyk J
    J Neuropathol Exp Neurol; 2016 May; 75(5):388-96. PubMed ID: 26979081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt.
    El-Sehemy A; Selvadurai H; Ortin-Martinez A; Pokrajac N; Mamatjan Y; Tachibana N; Rowland K; Lee L; Park N; Aldape K; Dirks P; Wallace VA
    J Clin Invest; 2020 Jun; 130(6):3069-3086. PubMed ID: 32182224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.
    Hara K; Kageji T; Mizobuchi Y; Kitazato KT; Okazaki T; Fujihara T; Nakajima K; Mure H; Kuwayama K; Hara T; Nagahiro S
    Cancer Lett; 2015 Jan; 356(2 Pt B):496-505. PubMed ID: 25301448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myometrial Cells Stimulate Self-Renewal of Endometrial Mesenchymal Stem-Like Cells Through WNT5A/β-Catenin Signaling.
    Cao M; Chan RWS; Cheng FHC; Li J; Li T; Pang RTK; Lee CL; Li RHW; Ng EHY; Chiu PCN; Yeung WSB
    Stem Cells; 2019 Nov; 37(11):1455-1466. PubMed ID: 31414525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways.
    Zins K; Schäfer R; Paulus P; Dobler S; Fakhari N; Sioud M; Aharinejad S; Abraham D
    Oncotarget; 2016 Jul; 7(29):46187-46202. PubMed ID: 27323822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.
    Kahlert UD; Suwala AK; Koch K; Natsumeda M; Orr BA; Hayashi M; Maciaczyk J; Eberhart CG
    J Neuropathol Exp Neurol; 2015 Sep; 74(9):889-900. PubMed ID: 26222502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.
    Götzel K; Chemnitzer O; Maurer L; Dietrich A; Eichfeld U; Lyros O; Moulla Y; Niebisch S; Mehdorn M; Jansen-Winkeln B; Vieth M; Hoffmeister A; Gockel I; Thieme R
    BMC Gastroenterol; 2019 Mar; 19(1):38. PubMed ID: 30841855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.
    Zhang W; Shen C; Li C; Yang G; Liu H; Chen X; Zhu D; Zou H; Zhen Y; Zhang D; Zhao S
    Mol Carcinog; 2016 May; 55(5):575-85. PubMed ID: 25764520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.
    Huang T; Alvarez AA; Pangeni RP; Horbinski CM; Lu S; Kim SH; James CD; J Raizer J; A Kessler J; Brenann CW; Sulman EP; Finocchiaro G; Tan M; Nishikawa R; Lu X; Nakano I; Hu B; Cheng SY
    Nat Commun; 2016 Oct; 7():12885. PubMed ID: 27698350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt5a attenuates Wnt3a-induced alkaline phosphatase expression in dental follicle cells.
    Sakisaka Y; Tsuchiya M; Nakamura T; Tamura M; Shimauchi H; Nemoto E
    Exp Cell Res; 2015 Aug; 336(1):85-93. PubMed ID: 26112214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
    Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
    Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.